| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 袁聪敏 | 中信证券 | 医药生物 | 31.29% | 24.94% | 33.69% | 33.33% | 5 | -2.06% | 2025-04-03 |
| 2 | 华挺 | 财通证券 | 医药生物 | 31.25% | 25.42% | 16.65% | -6.67% | 4 | -50.33% | 2025-06-10 |
| 3 | 华挺 | 财通证券 | 医药生物 | 31.23% | 25.47% | 17.08% | -6.67% | 4 | -50.33% | 2025-06-09 |
| 4 | 张林晚 | 上海证券 | 医药生物 | 31.17% | 33.41% | 32.78% | -100.00% | 1 | -18.93% | 2025-07-07 |
| 5 | 张林晚 | 上海证券 | 医药生物 | 31.17% | 31.17% | 18.06% | -100.00% | 1 | -18.93% | 2025-07-01 |
| 6 | 任晓帆 | 东海证券 | 医药生物 | 31.17% | 29.12% | 33.54% | 0.00% | 2 | -17.50% | 2025-07-17 |
| 7 | 仰佳佳 | 申万宏源 | 医药生物 | 31.17% | 31.12% | 23.05% | 16.67% | 1 | -37.64% | 2025-06-04 |
| 8 | 武煜 | 招银国际 | 医药生物 | 31.12% | 21.10% | 15.17% | 0.00% | 1 | -6.92% | 2025-06-09 |
| 9 | 武煜 | 招银国际 | 医药生物 | 31.11% | 31.17% | 18.07% | 0.00% | 2 | -6.92% | 2025-05-30 |
| 10 | 华挺 | 财通证券 | 医药生物 | 31.07% | 35.29% | 8.01% | -6.67% | 7 | -50.33% | 2025-07-11 |
| 11 | 袁聪敏 | 中信证券 | 医药生物 | 31.05% | 24.71% | 31.05% | 33.33% | 5 | -2.06% | 2025-04-01 |
| 12 | 阳景 | 浦银国际证券 | 医药生物 | 31.04% | 29.96% | 9.77% | 100.00% | 4 | 0.00% | 2025-06-17 |
| 13 | 仰佳佳 | 申万宏源 | 医药生物 | 31.03% | 31.00% | -3.20% | 16.67% | 1 | -37.64% | 2025-07-22 |
| 14 | 袁聪敏 | 中信证券 | 医药生物 | 31.01% | 24.67% | 22.82% | 33.33% | 3 | -2.06% | 2025-04-29 |
| 15 | 张林晚 | 上海证券 | 医药生物 | 30.97% | 34.62% | 20.00% | -100.00% | 1 | -18.93% | 2025-07-02 |
| 16 | 袁聪敏 | 中信证券 | 医药生物 | 30.97% | 24.64% | 23.24% | 33.33% | 5 | -2.06% | 2025-04-25 |
| 17 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 30.96% | 31.29% | 37.62% | 3.45% | 2 | -27.10% | 2025-04-10 |
| 18 | 仰佳佳 | 申万宏源 | 医药生物 | 30.93% | 32.17% | 31.86% | 16.67% | 3 | -37.64% | 2025-04-25 |
| 19 | 任晓帆 | 东海证券 | 医药生物 | 30.88% | 29.50% | 33.23% | 0.00% | 2 | -17.50% | 2025-07-16 |
| 20 | 袁聪敏 | 中信证券 | 医药生物 | 30.84% | 24.51% | 22.66% | 33.33% | 5 | -2.06% | 2025-04-28 |